3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Neoplasm Metastasis
3
Recurrence
2
Prostatic Neoplasms
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Nephrotic Syndrome
1
Kidney Diseases
1
Head and Neck Neoplasms
1
Glioblastoma
1
Gastrointestinal Diseases
1
Familial Mediterranean Fever
1
Fallopian Tube Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Ovarian Epithelial
1
Arthritis, Rheumatoid
1
Amyloidosis
1
All Solid Tumors
1
Interventions
Pharmaceutical Preparations
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
All Solid Tumors
×
Pharmaceutical Preparations
×
Clear all
NCT01711398
2015-02-12
IP N02
Elro Pharma
Phase 1/2
Completed
15 enrolled